HumanT-cell leukemia virus type 1 (HTLV-1)infection is considered to contribute to the risk of malignancies other than adult T-cell leukemia. Wereport a 64-year-old male HTLV-1 carrier whodeveloped quadruple malignancies such as cancer of the urinary bladder, skin, larynx and liver. (Internal Medicine 33: 155-157, 1994) 
Introduction
It is well knownthat humanT-cell leukemia virus type-1 (HTLV-1) is the causative pathogen of adult T-cell leukemia (ATL) (1) and HTLV-1 associated myelopathy (2) . HTLV-1 is also thought to alter the host immunefunction and to contribute to the development of other malignancies (3, 4) . In this report, we present an HTLV-1 carrier who developed quadruple carcinomas. To our knowledge, multiple cancers totaling four or more have not been reported previously in an HTLV-1 carrier.
Case Report A64-year-old manwas admitted to our hospital because of hoarseness in 1989. He and his parents were born in Osaka Prefecture, Japan and both parents had died of unknown cause. Twoof his older sisters had died of colon cancer and renal cancer, respectively. He had been a heavy drinker [360 ml of Japanese rice wine (sake) a day for 35 years] and smoker (15 cigarettes a day for 40 years). There was a history of bladder cancer (Fig. 1A) in 1982, shaped as a pedunculated papillary tumor, approximately 3 cm in size, and was treated with partial cystectomy and anti-cancer agents ofa total intravenous dose of 30 mg Mitomycin C, with Doxorubicin 1 ,350 mg and Cytarabin 13.5 kg given intrabladderly. At this time he received blood transfusions (9 units of preserved whole blood, 3 units of red cell concentrates and 21 units of fresh frozen plasma). In addition, he had a total resection of skin cancer (Fig. IB) Anti-HTLV-1 antibody was positive (x4,096) by particle agglutination test and determined by Western blotting. Antihepatitis C virus (HCV) antibody was also positive in the serum. Vocal code biopsy revealed squamous cell carcinoma ( Fig. 1C ) (T2N0M0, TNMclassification) and he was treated with irradiation in 1989. Also, an echographic examination of the abdomendisclosed a mass lesion, 2.6x2.6 cmin size, in the liver. He had a partial hepatectomy and was diagnosed as hepatocellular carcinoma (Fig. ID) with liver cirrhosis in the same year. Neither peripheral lymphnode swelling nor abnormal lymphocytes in the peripheral blood smear has been seen during the clinical course. He is alive nowand is followed up as an out-patient. 
Discussion
In this report, we describe a case of HTLV-1carrier who developed quadruple cancers. The patient was positive for anti-HTLV-1 antibody but lacked evidence of overt ATL such as lymph node swelling and abnormal lymphocytes in the peripheral blood smear. So, we diagnosed him as a carrier state of HTLV-1. In this case, two routes ofHTLV-1 infection, namely, from mother to child or from donor to recipient in blood transfusion were considered (6, 7). ATLhas a peculiar geographic distribution in the southwestern part of Japan (8, 9) . However,since the birthplace of the patient and his mother was not that area, the first route of HTLV-1infection is unlikely. Concerning the possibility of transmission from wife to husband, wecould not test his wife's serum due to her refusal. Thoughthis route can not be completely excluded, it is extremely rare (10) . Wethink that the blood transfusion was the more possible infectious route of HTLV-1 because the patient was transfused before the introduction of a screening system for anti-HTLV-1 antibody in Japan. At that time, he might have also been infected with HCV. Since the 1970's, many investigators have reported a tendency of multiple primary cancers with increasing incidence (1 1 , 12) . However, cases with multiple carcinomas totaling four or more are extremely rare (13) . A report from MayoClinic described only 5 cases (0.000 1 %) of quadruple or more primary cancers in 37,580 consecutive autopsy cases (14) . The occurrence of second malignancies due to anti-cancer drugs, especially alkylating agents, has been reported (15) . In the present case, Mitomycin C, Doxorubicin and Citarabin were administered for bladder cancer in 1982. To our knowledge, however, the malignancies induced by chemotherapy such as this regimen have not been documented previously. A high HTLV-1 seroprevalence in patients with malignancy irrespective of blood transfusion has been reported ( 16) . Although this issue is controversial (17), HTLV-1 infection was demonstrated to be directly or indirectly associated with the oncogenesis of a malignancy other than ATL(3, 18). Matsuzaki et al described monoclonal integration of HTLV-1 proviral DNAin small cell lung cancer cells and suggested its direct involvement in carcinogenesis ( 1 9). Our analysis of hepatocellular carcinoma cells did not have this finding. HTLV-1 infection is also thought to alter the host immunesurveillance system and to permit evolution of various malignancies (4) . The present patient did not showany evidence of immunedeficiency as far as we could determine. In this case, however, the development of multiple cancers other than the urinary bladder cancer mayhave been associated with HTLV-1 infection perhaps by indirect mechanisms though the details are unclear.
